Assignee
ONCOSEC MEDICAL INC
US·8 granted patents·14 pending applications·29 citations·filing 2013–2023
Top patents by PatentIndex Score
22 records- 0182US10426847B2Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2016·Granted Oct 1, 2019·7 cites·18 claims
- 0273US9020605B2Electroporation deviceONCOSEC MEDICAL INC·Filed 2013·Granted Apr 28, 2015·19 cites·19 claims
- 0368US11318305B2Systems and methods for improved tissue-sensing based electroporationONCOSEC MEDICAL INC·Filed 2016·Granted May 3, 2022·2 cites·23 claims
- 0465US11564999B2Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2019·Granted Jan 31, 2023·0 cites·14 claims
- 0560US2023272043A1Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2023·Application pending·0 cites
- 0659US11071860B2Systems and methods for detecting fault conditions in electroporation therapyONCOSEC MEDICAL INC·Filed 2019·Granted Jul 27, 2021·1 cites·20 claims
- 0759US2023001189A1Systems and methods for improved tissue-sensing based electroporationONCOSEC MEDICAL INC·Filed 2022·Application pending·0 cites
- 0858US2021062218A1Plasmid constructs for heterologous protein expression and methods of useONCOSEC MEDICAL INC·Filed 2020·Application pending·0 cites
- 0956US2021369813A9Modulating responses to checkpoint inhibitor therapyONCOSEC MEDICAL INC·Filed 2021·Application pending·0 cites
- 1055US11713467B2Plasmid constructs for heterologous protein expression and methods of useONCOSEC MEDICAL INC·Filed 2016·Granted Aug 1, 2023·0 cites·14 claims
- 1153US11007365B2Method and device for treating microscopic residual tumors remaining in tissues following surgical resectionONCOSEC MEDICAL INC·Filed 2017·Granted May 18, 2021·0 cites·20 claims
- 1252US12109411B2Systems and methods for detecting fault conditions in electroporation therapyONCOSEC MEDICAL INC·Filed 2021·Granted Oct 8, 2024·0 cites·18 claims
- 1352US2023302090A1Combination therapy for treatment of cancerONCOSEC MEDICAL INC·Filed 2021·Application pending·0 cites
- 1451US2019209652A1Modulating responses to checkpoint inhibitor therapyONCOSEC MEDICAL INC·Filed 2017·Application pending·0 cites
- 1550US2023277624A1Methods of determining responsiveness to cancer immunotherapyONCOSEC MEDICAL INC·Filed 2021·Application pending·0 cites
- 1650US2020316376A1Electroporation systems, methods, and apparatusONCOSEC MEDICAL INC·Filed 2020·Application pending·0 cites
- 1749US2019336757A1Electroporation systems, methods, and apparatusONCOSEC MEDICAL INC·Filed 2019·Application pending·0 cites
- 1842US2022040328A1Multigene construct for immune-modulatory protein expression and methods of useONCOSEC MEDICAL INC·Filed 2019·Application pending·0 cites
- 1941US2023256236A1Transformable needle for electroporationONCOSEC MEDICAL INC·Filed 2021·Application pending·0 cites
- 2035US2020123566A1Multigene construct for immune-modulatory protein expression and methods of useONCOSEC MEDICAL INC·Filed 2018·Application pending·0 cites
- 2135US2018000895A1Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2016·Application pending·0 cites
- 2233US2015297887A1Electroporation deviceONCOSEC MEDICAL INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCOSEC MEDICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →